Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd W Miller

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Molecular & Cellular Oncology|June 17, 2016
The PREX1/Rac signaling axis: Potential as a biomarker and therapeutic target in breast cancerLloye M Dillon, Todd W Miller
Current Drug Targets|January 7, 2014
Therapeutic targeting of cancers with loss of PTEN functionLloye M Dillon, Todd W Miller
Cancer Informatics|April 2, 2021
Pan-Cancer Transcriptional Models Predicting Chemosensitivity in Human TumorsJason D Wells, Jacqueline R Griffin, Todd W Miller
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2011
Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancerTodd W Miller, Justin M Balko, Carlos L Arteaga
Frontiers in Oncology|October 23, 2012
Abrogating endocrine resistance by targeting ERα and PI3K in breast cancerEmily M Fox, Carlos L Arteaga, Todd W Miller
Journal of Cellular Biochemistry|May 6, 2016
Clinical Implementation of Novel Targeted Therapeutics in Advanced Breast CancerMary D Chamberlin, Erica B Bernhardt, Todd W Miller
Plos One|November 5, 2019
Integrated pan-cancer gene expression and drug sensitivity analysis reveals SLFN11 mRNA as a solid tumor biomarker predictive of sensitivity to DNA-damaging chemotherapyKevin Shee, Jason D Wells, Amanda Jiang, et al.
Marine Pollution Bulletin|July 3, 2010
Tracing anthropogenic inputs to production in the Seto Inland Sea, Japan--a stable isotope approachTodd W Miller, Koji Omori, Hideki Hamaoka, et al.
Breast Cancer Research : BCR|November 26, 2011
Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancerTodd W Miller, Brent N Rexer, Joan T Garrett, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 30, 2003
DNA vaccination against mutant huntingtin ameliorates the HDR6/2 diabetic phenotypeTodd W Miller, Thomas L Shirley, William J Wolfgang, et al.
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Molecular & Cellular Oncology|June 17, 2016
The PREX1/Rac signaling axis: Potential as a biomarker and therapeutic target in breast cancerLloye M Dillon, Todd W Miller
Current Drug Targets|January 7, 2014
Therapeutic targeting of cancers with loss of PTEN functionLloye M Dillon, Todd W Miller
Cancer Informatics|April 2, 2021
Pan-Cancer Transcriptional Models Predicting Chemosensitivity in Human TumorsJason D Wells, Jacqueline R Griffin, Todd W Miller
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2011
Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancerTodd W Miller, Justin M Balko, Carlos L Arteaga
Frontiers in Oncology|October 23, 2012
Abrogating endocrine resistance by targeting ERα and PI3K in breast cancerEmily M Fox, Carlos L Arteaga, Todd W Miller
Journal of Cellular Biochemistry|May 6, 2016
Clinical Implementation of Novel Targeted Therapeutics in Advanced Breast CancerMary D Chamberlin, Erica B Bernhardt, Todd W Miller
Plos One|November 5, 2019
Integrated pan-cancer gene expression and drug sensitivity analysis reveals SLFN11 mRNA as a solid tumor biomarker predictive of sensitivity to DNA-damaging chemotherapyKevin Shee, Jason D Wells, Amanda Jiang, et al.
Marine Pollution Bulletin|July 3, 2010
Tracing anthropogenic inputs to production in the Seto Inland Sea, Japan--a stable isotope approachTodd W Miller, Koji Omori, Hideki Hamaoka, et al.
Breast Cancer Research : BCR|November 26, 2011
Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancerTodd W Miller, Brent N Rexer, Joan T Garrett, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 30, 2003
DNA vaccination against mutant huntingtin ameliorates the HDR6/2 diabetic phenotypeTodd W Miller, Thomas L Shirley, William J Wolfgang, et al.
Pageof 9